Eli Lilly plans four new U.S. manufacturing sites, expanding domestic production and reshoring pharmaceutical ingredient manufacturing. $50B expansion since 2020 includes four sites, creating over ...

Eli Lilly (LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the production of key drug ingredients. Three of the four sites will produce ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

Compounding pharmacies that have been selling hundreds of thousands of doses of copies of Lilly's Zepbound and Novo's Wegovy while the medicines were in shortage are running out of time to produce ...

“Was anyone else EXTREMELY UNCOMFORTABLE when jane fonda was being interviewed by lilly singh on the sag red carpet just now? it was so awkward and difficult to watch, jane looked like she ...

Since Joseph Krug started his eponymous Champagne house in 1843, the maison had been making its annual Grande Cuvée release in the region’s largest city, Reims. Last year, the company moved to ...

Lilly Singh was one of YouTube's biggest and brightest stars. She earned millions of views, collaborated with celebrities, and even managed to transition her career offline into a barrier-breaking ...

His dad is British actor Malcolm McDowell, with whom Steenburgen shares McDowell (41) and his sister Lilly McDowell Walton (44). Steenburgen divorced Malcolm in 1991 and married The Good Place and ...

For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...

It isn't a cheap buy, but given its strong growth prospects, a premium is justifiable. Lilly could obtain approval for a weight loss pill that would unlock even more growth. Investors should never ...

Eli Lil­ly has shared first-in-hu­man re­sults for its se­lec­tive FGFR3 in­hibitor in a sub­set of blad­der can­cer pa­tients, mark­ing the start of a pro­gram that … ...